Best Altcoins to Buy Now: 3 Crypto Picks if the July Recovery Continues

• Render: AI infrastructure demand and expanded GPU capacity support long-term growth potential.

• Injective: Mature DeFi ecosystem and low valuation offer strong upside during market recovery.

• Kaspa: Smart contracts and lower token emissions strengthen long-term adoption prospects.

The crypto market has started showing signs of strength after months of uncertainty. Many investors now search for projects with solid fundamentals instead of chasing short-term hype. A lasting recovery could reward networks that continue building through weaker markets. Render, Injective, and Kaspa all fit that profile. Each project focuses on a different sector, giving investors several ways to benefit if positive market momentum continues through the rest of July.

Render (RNDR)

Source: Trading View

Render provides decentralized computing power for graphics rendering and artificial intelligence workloads. Users needing high-performance GPUs connect with owners willing to rent unused hardware. That model creates an efficient marketplace while supporting growing demand from AI developers, digital artists, and content creators. Recent network improvements have strengthened future growth potential. A governance proposal expanded network capacity by adding tens of thousands of GPUs through a new subnet. Greater computing resources allow more users to access services without creating bottlenecks. Artificial intelligence remains one of the strongest investment themes during 2026. Render offers direct exposure to that trend through real infrastructure instead of speculation alone.

Injective (INJ)

Source: Trading View

Injective focuses on decentralized finance and offers infrastructure built for financial applications. Developers can create decentralized exchanges, lending platforms, derivatives markets, and prediction markets on a fast blockchain with low transaction costs. Full on-chain order books also give traders features normally associated with centralized exchanges. Cross-chain compatibility strengthens broader adoption. Support for Ethereum and Solana allows assets and liquidity to move across ecosystems more efficiently. Despite processing more than one billion transactions, Injective still carries a market capitalization below $500 million. That combination gives investors exposure to an established ecosystem without paying premium valuations. Stronger DeFi activity during a broader recovery could place Injective among the strongest performers in the sector.

Kaspa (KAS)

Source: Trading View

Kaspa takes a different approach by combining proof-of-work security with very fast transaction processing. The network uses GHOSTDAG technology to improve throughput while maintaining decentralization. Fast confirmation times have already made Kaspa attractive for payment use cases. A major milestone arrived with the Toccata hard fork on June 30, 2026. Native smart contracts and token support transformed Kaspa into a programmable blockchain. Developers can now build decentralized applications directly on the network. That upgrade opens fresh opportunities for ecosystem growth during coming months. Fair token distribution without a pre-mine also strengthens long-term confidence. Declining token emissions reduce future supply growth, creating another positive factor for long-term holders.

Render benefits from growing demand for decentralized AI computing infrastructure. Injective combines mature DeFi technology with an attractive valuation. Kaspa enters a new growth phase after adding smart contracts and token support. Together, these three projects deserve attention if the July crypto recovery continues.